You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

List of Excipients in API loperamide hcl


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing loperamide hcl

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
ASSURED / DOLLAR TREE (Greenbrier International Inc) ANTI-DIARRHEAL loperamide hcl 33992-0520 BUTYLATED HYDROXYANISOLE
ASSURED / DOLLAR TREE (Greenbrier International Inc) ANTI-DIARRHEAL loperamide hcl 33992-0520 FD&C BLUE NO. 1
ASSURED / DOLLAR TREE (Greenbrier International Inc) ANTI-DIARRHEAL loperamide hcl 33992-0520 GELATIN
ASSURED / DOLLAR TREE (Greenbrier International Inc) ANTI-DIARRHEAL loperamide hcl 33992-0520 GLYCERIN
ASSURED / DOLLAR TREE (Greenbrier International Inc) ANTI-DIARRHEAL loperamide hcl 33992-0520 GLYCERYL MONOCAPRYLATE
ASSURED / DOLLAR TREE (Greenbrier International Inc) ANTI-DIARRHEAL loperamide hcl 33992-0520 POLYOXYL 40 HYDROGENATED CASTOR OIL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing loperamide hcl

Company Ingredient NDC Excipient
L Perrigo Company loperamide hcl 0113-0645 ANHYDROUS CITRIC ACID
L Perrigo Company loperamide hcl 0113-0645 CARBOXYMETHYLCELLULOSE SODIUM
L Perrigo Company loperamide hcl 0113-0645 CELLULOSE, MICROCRYSTALLINE
L Perrigo Company loperamide hcl 0113-0645 D&C YELLOW NO. 10
L Perrigo Company loperamide hcl 0113-0645 FD&C BLUE NO. 1
L Perrigo Company loperamide hcl 0113-0645 GLYCERIN
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for loperamide hcl

Excipient focus: ALCOHOL

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZOIC ACID

Excipient focus: BUTYLATED HYDROXYANISOLE

Excipient focus: CALCIUM SILICATE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

loperamide hcl drug variants not containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Honeywell Safety Products USA Inc loperamide hcl 0498-1071
Rebel Distributors Corp loperamide hcl 21695-978
ASSURED / DOLLAR TREE (Greenbrier International Inc) loperamide hcl 33992-0520
Lil' Drug Store Products Inc loperamide hcl 66715-6359
Cardinal Health (Leader) 70000 loperamide hcl 70000-0230
Lil' Drug Store Products Inc loperamide hcl tablet 66715-5529
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CORN OIL

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: DIMETHICONE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONOCAPRYLATE

Excipient focus: HYDROGENATED COTTONSEED OIL

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL

Excipient focus: POWDERED CELLULOSE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group